You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The deal covers Agena's MassArray platform for genetic variant measurement, as well as genetic testing applications and other related products.
The firm has collaborated with Novartis to help pilot the new sickle cell disease test and a treatment in Ghana.
In preliminary findings in 28 symptomatic patients, the test diagnosed infection with a sensitivity of 92 percent and specificity of 100 percent.
Under a licensing deal, Omixon will sell the AzureSeq-200 RT-PCR kit under its brand in Europe, the Middle East, and Africa.
The test uses real-time reverse transcription loop-mediated isothermal amplification to detect the SARS-CoV-2 N gene, according to CellSafe.
Over six months, Abbott and SD Biosensor will provide rapid antigen tests to a variety of countries at a maximum price of $5 per test.
The diagnostics are capable of detecting fewer than two parasites per microliter of blood and would cost an estimated $.61 per test.
FIND has convened the Access to COVID-19 Tools Accelerator Diagnostic Pillar to supply 500 million tests to countries in the next year.
Caspr's assay can be transported at room temperature and performed without complex external equipment, making it ideal for low-resource environments.
The firm launched a CE-IVD marked test for extremely drug-resistant TB and expects to incorporate the multiplexing technology in other assays.
